World Bank Health Loan For Bulgaria
Bulgaria has been granted a $26 million loan by the World Bank for its health sector restructuring program, which will cost $47.1 million in all. The government is investing $7.8 million in the improvements.
The World Bank project is in four parts, the first to improve health service management, the second to improve primary health care in 75 municipal health services ($14.6 million) and the other two for the development of a well-organized national system of emergency medical aid, together with improvements to the blood transfusion and collection service.
Other Eastern European News - Small pharmacies and other outlets selling drugs in the Czech Republic recorded massive growth in sales revenue this February over February 1995, reports the CTK news agency's Business News.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze